Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Sustained ophthalmic in situ gel of ketorolac tromethamine
Drug Development Research, 09/16/09
Manjappa AS et al. – The formulation with benzalkonium chloride and edetate disodium improved the rate of corneal absorption but not the extent. The developed formulation is a viable alternative to conventional eye drops by virtue of its ability to enhance bioavailability through its longer precorneal residence time and ability to sustain drug release. Also importantly is the ease of instillation afforded and decreased frequency of instillation resulting in better patient acceptance.
Related Articles
Ketorolac tromethamine 0.4% to relieve eye pain and inflammation following cataract extraction and keratorefractive surgery
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09
Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis
International Ophthalmology, 12/16/09
Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/16/09
Article Search
Sponsor


See Latest Articles


